Biktarvy, formally known as bictegravir, represents a powerful single-tablet regimen for managing HIV infection. This formula combines three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the HIV's ability to replicate within the body, remarkably decreasing the viral quantity. For many i